Clinical Expertise Functional Expertise Industry Expertise Biotechnology Diagnostics Discovery and Development Drug Delivery Medical Devices Not-for-Profit Organizations Pharmaceutical Companies Private Equity Companies Venture-Backed Companies Focus Areas Private Equity While few markets remain as attractive for investors as healthcare products, generating exceptional returns is increasingly difficult. IPOs are less likely to provide an exit strategy for early-stage investors while strategic buyers' appetites for acquisitions are increasing. Venture-backed companies must choose their business models and development priorities carefully in order to maximize exit options and valuations. Leveraged buyouts of companies in sectors with low technology risk have earned high returns. However, this success has led to very competitive auctions. Timely due diligence is essential to be competitive in pricing deals. Venture-Backed Companies Opportunity assessment Technology planning Program prioritization Business development plans Strategy options Leveraged Buyout Firms Opportunity identification Due diligence Valuation Strategic repositioning Asset maximization Selected Experience learn more about our work with private equity companies.

Health Advances All Rights Reserved.